The medical cannabis product is launched under the brand IndiMed and manufactured at Aurora's EU-GMP facility in Leuna, Germany.
Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.
Aurora Cannabis (TSX:ACB), a global cannabis stock, is releasing its first German-cultivated dried flower product under the IndiMed brand on January 27 ・The strain, Island Sweet Skunk, is a ...
Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...
HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.
Imexpharm Corporation has announced its 2024 financial results with net revenue reaching VND2,205 billion, up 10.6 percent year on year, driven by robust growth in ETC channel and high-quality ...
Venus Remedies secures EU GMP renewal from Infarmed, strengthens European market presence: Our Bureau, Bengaluru Wednesday, January 22, 2025, 15:30 Hrs [IST] Venus Remedies has an ...
Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...
Curaleaf Holdings down 68% in a year, with 66 dispensaries in Florida. Q324 showed in-line results and international growth.
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“ HYTN ” or the “Company ”), a pharmaceutical company specializing in pharmaceutical-grade cannabis manufacturing is pleased to announce ...